VMP 42086111000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Pioglitazone 15mg / Metformin 850mg tablets
BNF code 0601023W0AAAAAA
Virtual Therapeutic Moiety Pioglitazone + Metformin
Date identifier became valid 21 Jul 2023
Previous product identifier 419873003
Basis of preferred name Other
Date of name applicability 1 Jun 2010
Previous name Metformin 850mg / Pioglitazone 15mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Metformin hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 850.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Pioglitazone hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 395828009
Strength value numerator 15.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Competact 15mg/850mg tablets (Lexon (UK) Ltd)
Competact 15mg/850mg tablets (Neon Healthcare Ltd)
Competact 15mg/850mg tablets (Sigma Pharmaceuticals Plc)
Pioglitazone 15mg / Metformin 850mg tablets (A A H Pharmaceuticals Ltd)
Pioglitazone 15mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd)
Pioglitazone 15mg / Metformin 850mg tablets (Medihealth (Northern) Ltd)
Pioglitazone 15mg / Metformin 850mg tablets (Teva UK Ltd)
Pioglitazone 15mg / Metformin 850mg tablets (Torrent Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Pioglitazone 15mg / Metformin 850mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback